13 completed. 13 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Completed 13 |
| Phase 2 | 3 | Completed 3 |
Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S QBS10072S - Astrocytoma, Brain Cancer | Phase 1 | Completed | Quadriga Biosciences, Inc. | 15 | 2020-07-20 | 2023-01-18 |
| Proof-of-concept Study of LUNA Intervention in Aphasia LUNA - Aphasia, Stroke | Phase 1 | Completed | City, University of London | 28 | 2020-06-14 | 2023-05-06 |
| Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs). - Language Delay, Language; Developmental Disorder, Expressive | Phase 1 / Phase 2 | Completed | Russian Academy of Medical Sciences | 14 | 2020-02-01 | 2022-05-02 |
| Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia F-18 AV 1451 - Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia | Phase 1 | Completed | Mayo Clinic | 81 | 2016-07-01 | 2025-11-21 |
| Brief Behavioral Treatment for Anxiety in Young Children Parent-Led Exposure Therapy, Treatment As Usual - Obsessive-compulsive Disorder, Social Phobia | Phase 1 / Phase 2 | Completed | University of South Florida | 58 | 2014-01-01 | 2016-10-06 |
| Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD C-11 PiB - Atypical Alzheimers Disease, Logopenic Variant of Primary Progressive Aphasia (LPA) | Phase 1 | Completed | Mayo Clinic | 27 | 2012-11-01 | 2015-12-21 |
| Transcranial Direct Current Stimulation and Aphasia Language Therapy Transcranial Direct Current Stimulation - Cathodal stimulation, Transcranial Direct Current Stimulation - Anodal stimulation, Transcranial Direct Current Stimulation - Sham stimulation - Nonfluent Aphasia, Stroke | Phase 1 | Completed | Shirley Ryan AbilityLab | 12 | 2010-03-01 | 2017-05-15 |
| PiB PET Scanning in Speech and Language Based Dementias C-11 PiB, F-18 FDG - PPA, Primary Progressive Aphasia | Phase 1 | Completed | Mayo Clinic | 168 | 2010-03-01 | 2015-12-22 |
| Davunetide (AL-108) in Predicted Tauopathies - Pilot Study davunetide (AL-108, NAP), Placebo nasal spray - Predicted Tauopathies, Including, Progressive Supranuclear Palsy | Phase 1 | Completed | University of California, San Francisco | 12 | 2010-01-01 | 2019-04-05 |
| Treating Intention In Aphasia: Neuroplastic Substrates Word-finding with intention component, Word-finding with no intention component - Aphasia, Cerebrovascular Accident | Phase 1 / Phase 2 | Completed | University of Florida | 14 | 2007-03-01 | 2012-05-03 |
| Improve Speech Using an In-the-ear Device in Parkinson's Disease SpeechEasy Model ITC - Parkinson's Disease, Dysarthria | Phase 1 | Completed | Rush University Medical Center | 40 | 2006-06-01 | 2013-01-18 |
| Assessment of Cortical Stimulation Combined With Rehabilitation to Enhance Recovery in Broca's Aphasia. Cortical Electrical Stimulation - Stroke, Broca's Aphasia | Phase 1 | Completed | Northstar Neuroscience | 8 | 2004-12-01 | 2007-09-21 |
| Transcranial Magnetic Stimulation to Improve Speech in Aphasia Transcranial Magnetic Stimulation, Repetitive - Aphasia, Cerebrovascular Stroke | Phase 1 | Completed | Boston University | 63 | 2002-07-01 | 2017-01-31 |
Aphasia (6) · Stroke (5) · Aphasia, Broca (3) · Language (3) · Aphasia, Primary Progressive (2) · Frontotemporal Dementia (2) · Ischemic Stroke (2) · Primary Progressive Nonfluent Aphasia (2) · Speech (2) · Anorexia (1) · Anxiety Disorders (1) · Anxiety, Separation (1) · Apraxias (1) · Astrocytoma (1)
Communication Disorders (13) · Nervous System Diseases (13) · Neurobehavioral Manifestations (13) · Neurologic Manifestations (13) · Pathological Conditions, Signs and Symptoms (13) · Signs and Symptoms (13) · Language Disorders (12) · Brain Diseases (10) · Central Nervous System Diseases (10) · Behavior (5) · Cardiovascular Diseases (5) · Cerebrovascular Disorders (5) · Communication (5) · Mental Disorders (5)
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (2) · Therapeutics (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1) · davunetide (1)
Mayo Clinic (3) · Boston University (1) · City, University of London (1) · Northstar Neuroscience (1) · Quadriga Biosciences, Inc. (1) · Rush University Medical Center (1) · Russian Academy of Medical Sciences (1) · Shirley Ryan AbilityLab (1) · University of California, San Francisco (1) · University of Florida (1) · University of South Florida (1)
United States (10) · Australia (1) · Russia (1) · United Kingdom (1)
Adam L. Boxer, M.D., Ph.D. (1) · Alexander A Ostanin, MD, PhD (1) · Alvaro Pascual-Leone, M.D., Ph.D. (1) · Bruce Crosson, PhD (1) · Elena R Chernykh, MD, PhD (1) · Emily Wang, PHD (1) · H B Coslett, M.D. (1) · Jennifer Whitwell, PhD (1) · Keith A Josephs, M.D. (1) · Keith A Josephs, M.D. MST, MSc (1) · Leo Verhagen, MD, PHD (1) · Leora R Cherney, PhD (1) · Margaret A Naeser, Ph.D. (1)
PMID 15118944, PMID 15766771, PMID 16006338, PMID 19695692, PMID 20159655, PMID 20299861, PMID 21794852, PMID 21864891, PMID 23280015, PMID 26704258, PMID 29256908, PMID 38875279
R01DC005672 (1), R01DC007387 (1), R21DC009876 (1), R21NS094684 (1)